Clinical Trials Directory

Trials / Completed

CompletedNCT03332654

Stress Urinary Incontinence in Women With Multiple Sclerosis

Prevalence and Risk Factors of Stress Urinary Incontinence in Women With Multiple Sclerosis

Status
Completed
Phase
Study type
Observational
Enrollment
363 (actual)
Sponsor
Lille Catholic University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Objective: To report the prevalence and risk factors of stress urinary incontinence (SUI) and the prevalence of intrinsic sphincter deficiency in women with multiple sclerosis (MS). Methods: A retrospective study was conducted among Female patients with MS, followed for lower urinary tract symptoms (LUTS) during a 15-year period. Demographic data, MS history, expanded disability status scale (EDSS) score at the urodynamic visit, obstetrical past, birth weight, LUTS, and urodynamic findings were collected. SUI was defined as incontinence during cough, or any effort. A maximum urethral closure pressure less than 30 cm H2O defined intrinsic sphincter deficiency. Results: In total 363 women with a mean age of 46.7±10.8 years and a mean disease duration of 12.9±8.7 years were included. The incidence of relapsing remitting MS, a secondary progressive form, and a primary progressive form was 60.6%, 32.8%, and 6.6%, respectively. The prevalence of SUI was 31.4%. The prevalence of intrinsic sphincter deficiency was 1.4% and 0.8% of these patients had a SUI (P=0.300). In a multivariate analysis, women with a SUI had significantly higher birth weight (P=0.030), a pelvic organ prolapse (P=0.021), urgent urinary incontinence (P=0.006), a lower EDSS score (P=0.019), and a weaker containing effort (P\<0.001). Conclusions: The prevalence of SUI in women with MS was 31.4%. This symptom could affect the quality of life of women with MS.

Conditions

Interventions

TypeNameDescription
OTHERDetermine prevalence of stress urinary incontinence

Timeline

Start date
2015-02-01
Primary completion
2016-01-31
Completion
2016-03-31
First posted
2017-11-06
Last updated
2017-11-06

Source: ClinicalTrials.gov record NCT03332654. Inclusion in this directory is not an endorsement.